{
  "ptid_time": "053_S_5208_2013-06-17",
  "img_path": "/data/qiuhui/data/adni/images/053_S_5208/2013-06-17/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 53,278 mm³, 77.4% above the reference mean. With a Z-score of 1.84 (96.7th percentile), this represents moderate enlargement; whole brain volume measures 1,208,520 mm³, 6.5% above the reference mean. With a Z-score of 0.92 (82.2th percentile), this represents normal volume ; entorhinal cortex volume measures 2,602 mm³, 39.0% below the reference mean. With a Z-score of -2.70 (0.4th percentile), this represents significant atrophy; fusiform gyrus volume measures 19,981 mm³, 0.4% above the reference mean. With a Z-score of 0.03 (51.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,049 mm³, 1.6% below the reference mean. With a Z-score of -0.13 (44.7th percentile), this represents normal volume . ",
  "text_data": "Age is 68.7 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Endocrine-Metabolic; Smoking; Major Surgical Procedures. MMSE: 26.0. MoCA: 17.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.07 SUVR (normal ); Total tau: 316.50 pg/mL (normal ); Phosphorylated tau: 24.71 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant atrophy in the entorhinal cortex (Z-score -2.70, 0.4th percentile), which is strongly associated with Alzheimer's pathology, alongside moderate ventricular enlargement. The MMSE (26) is borderline, but the MoCA (17) indicates cognitive impairment. Normal CSF biomarkers (T-tau, P-tau, AV45) and no APOE4 allele suggest a non-AD etiology, but the entorhinal atrophy and cognitive deficits are concerning.  \n\n**Diagnosis:** **MCI** (likely non-Alzheimer’s etiology, possibly vascular or other neurodegenerative cause)  \n**Confidence:** **Medium** (entorhinal atrophy and MoCA strongly suggest impairment, but normal biomarkers and lack of APOE4 reduce certainty for AD-specific dementia).",
  "timestamp": "2025-07-26T08:01:45.825585"
}